Zealand Pharma sells insulin pump to Mannkind Corporation

On Tuesday, Zealand Pharma reports that a deal has been struck with US-based Mannkind Corporation entailing the sale of V-Go, an insulin pump. (Updated)

Photo: Zealand Pharma / PR

Zealand Pharma, a biotech firm publicly listed in Denmark that has been undergoing comprehensive structural changes since March, announced on Tuesday that it has sold its insulin pump, dubbed V-Go, to US-based firm Mannkind Corporation.

Under the terms of the deal, Zealand Pharma receives an upfront USD 10m payment in addition to undisclosed sales-based milestones.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs